Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senator drafts US bill aimed at safeguarding supply chain, but lacking inspection fees

This article was originally published in Scrip

Executive Summary

Congress may be preparing for the August recess, but US Senator Michael Bennet (Democrat, Colorado), has decided that it would be a good time to introduce a bill providing the FDA with mandatory recall authority and greater oversight of manufacturing quality for both foreign and domestic companies so that lawmakers could consider the issues when they reconvene. In tackling such a debated issue as how to oversee a pharmaceutical supply chain that has become globalised, Bennet's bill faces an uncertain future; it will now be referred to a health committee.

Topics

UsernamePublicRestriction

Register

SC009799

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel